Herlitz J, Brorsson B, Werkö L
Division of Cardiology, Sahlgrenska University Hospital, Göteborg, Sweden.
J Intern Med. 1999 Feb;245(2):143-53. doi: 10.1046/j.1365-2796.1999.0425f.x.
To describe variations by age, sex, symptom severity and hospital region in the use of various medications amongst patients with stable angina pectoris who are candidates for coronary revascularization.
Patients (n = 2030) with chronic stable angina pectoris participating in a national survey evaluating the appropriateness of the use of percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass grafting (CABG).
As part of a national study of the appropriateness of coronary revascularization, data were prospectively collected on patients referred for consideration of coronary revascularization to seven of the eight public Swedish heart centres that performed approximately 92% of all bypass operations in Sweden in 1994.
Amongst all patients 76% were treated with beta blockers, 41% with calcium antagonists and 71% with long-acting nitrates and 70% were treated with at least two of these three drugs. Eighty-two per cent of the patients used aspirin and 14% lipid-lowering drugs. According to logistic regression analysis, with medication as the dependent variable and independent variables of age, sex, angina functional class, findings at exercise test, history of various diseases and region in Sweden where the investigation took place, the most consistent factor explaining the use of various medications was found to be geographical region. A previous history of acute myocardial infarction (AMI) was also associated with the use of all drugs and age was associated with all with the exception of beta blockers. Sex was not an independent factor explaining the use of any of the drugs.
In a national survey including patients with stable angina pectoris who are potential candidates for coronary revascularization, the most important predictor for the use of various medications was the geographical region in which the investigation took place.
描述年龄、性别、症状严重程度及医院所在地区对适合进行冠状动脉血运重建的稳定型心绞痛患者使用各类药物的影响。
2030例慢性稳定型心绞痛患者参与了一项全国性调查,该调查旨在评估经皮腔内冠状动脉成形术(PTCA)和冠状动脉旁路移植术(CABG)使用的合理性。
作为一项关于冠状动脉血运重建合理性的全国性研究的一部分,前瞻性收集了被转诊考虑进行冠状动脉血运重建的患者的数据,这些患者来自瑞典八个公立心脏中心中的七个,这七个中心在1994年进行了瑞典约92%的搭桥手术。
在所有患者中,76%接受β受体阻滞剂治疗,41%接受钙拮抗剂治疗,71%接受长效硝酸盐治疗,70%接受这三种药物中的至少两种治疗。82%的患者使用阿司匹林,14%使用降脂药物。根据逻辑回归分析,以药物使用作为因变量,年龄、性别、心绞痛功能分级、运动试验结果、各种疾病史以及调查所在的瑞典地区作为自变量发现,解释各类药物使用的最一致因素是地理区域。急性心肌梗死(AMI)病史也与所有药物的使用相关,年龄与除β受体阻滞剂外的所有药物使用相关。性别不是解释任何一种药物使用的独立因素。
在一项纳入适合进行冠状动脉血运重建的稳定型心绞痛患者的全国性调查中,各类药物使用的最重要预测因素是调查所在的地理区域。